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ABSTRACT
Eosinophilic airway inflammation and increased cough
sensitivity without bronchial hyperresponsiveness are
the pathologic and physiologic features of bron-
chodilator-resistant non-productive cough-associated
global atopic tendency, abbreviated herein as atopic
cough. Histamine H1 receptor antagonists are effective
in relieving the cough in nearly 60% of patients with
atopic cough. However, there is no direct evidence that
histamine H1 receptor antagonists can reduce cough
hypersensitivity associated with eosinophilic airway
inflammation. The purpose of the present study was to
clarify this issue. The number of coughs caused by
inhalation of increasing concentrations of capsaicin
(10–8, 10–6 and 10–4 mol/L) was counted 24 h after the
administration of an aerosolized antigen in actively
sensitized conscious guinea pigs and then bron-
choalveolar lavage (BAL) was performed. Azelastine
(0.1 or 1 mg/kg) or terfenadine (0.2 or 2 mg/kg) was
given intraperitoneally 60 min before capsaicin provo-
cation 24 h after the antigen challenge in sensitized
guinea pigs. In addition, azelastine (0.1 or 1 mg/kg)
was administered 90 min before the capsaicin chal-
lenge in naïve guinea pigs. The cough response to
capsaicin and the number of eosinophils in BAL fluid
(BALF) were significantly increased after antigen chal-
lenge. Azelastine and terfenadine significantly reduced
the increased cough response after antigen challenge,
while azelastine had no effect in naïve animals. In 
conclusion, histamine H1 receptor antagonists reduce
antigen-induced increases in cough sensitivity in sensi-
tized guinea pigs without direct inhibition of a common
cough reflex pathway.
Key words: allergic reaction, capsaicin, cough sensi-
tivity, guinea pig, histamine H1 receptor antagonists.
INTRODUCTION
A new clinical entity, presenting with chronic broncho-
dilator-resistant non-productive cough associated with
global atopic tendency, abbreviated here as atopic
cough, in which eosinophilic inflammation of airways
and increased cough sensitivity are the respective funda-
mental pathologic and physiologic features has been
proposed.1–3 Histamine H1 receptor antagonists are
effective in treating cough in nearly of 60% patients with
atopic cough.1–3 Recently, three cases of atopic cough
have been reported4–6 in which a single inhalation chal-
lenge with environmental fungal antigen extract caused
non-productive cough and increased cough sensitivity to
inhaled capsaicin. On the basis of these findings it is
hypothesized that a single antigen challenge is able to
cause an increase in cough sensitivity associated with
airway eosinophilic inflammation.
Many animal experiments have been performed to
assess the antitussive effect of various agents. Bolser 
el al.7 have reported that the antihistamines loratadine
and chlorpheniramine inhibited antigen-induced cough
in actively sensitized guinea pigs and capsaicin-induced
cough in naïve guinea pigs. However, they did not
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examine whether the antigen-induced cough resulted
from an increased cough reflex or bronchoconstriction
induced by an allergic reaction. Thus, the effect of anti-
histamines on heightened cough sensitivity induced by
allergic reactions has never been reported. 
Although it has been shown that multiple antigen 
challenges increase cough responses to inhaled capsaicin
in sensitized guinea pigs,8 the effect of a single antigen
challenge on cough sensitivity has not been reported. The
present study was conducted to elucidate whether airway
cough response to inhaled capsaicin is increased after a
single antigen challenge in actively sensitized guinea pigs
and whether histamine H1 receptor antagonists inhibit the
antigen-induced increase in the cough response.
METHODS
Animals
Male albino Hartley guinea pigs, weighing 200–250 g,
were obtained from Sankyo Laboratory Service (Toyama,
Japan). They were quarantined in the Animal Research
Center of Kanazawa University for 1 week before the
study. All animal procedures in the present study com-
plied with the standards set out in the Guideline for the
Care and Use of Laboratory Animals in Takara-machi
Campus of Kanazawa University.
Sensitization of animals
Guinea pigs were actively sensitized by the method
reported by Muraki et al.9 Guinea pigs were administered
2.0 mg, i.p., ovalbumin (OA) and 100 mg, i.p., alu-
minum hydroxide (Al(OH)3) 2 days after intraperitoneal
administration of 30 mg/kg cyclophosphamide. Boosting
was performed by the intraperitoneal administration of
0.01 mg OA and 100 mg Al(OH)3 3 weeks later.
Antigen challenge
Actively sensitized conscious guinea pigs were placed in
a dual chamber plethysmograph (head chamber volume
1520 mL; model PMUA + SAR; Buxco Electronics,
Sharon, CT, USA). Animals were challenged with a 10
mg/mL OA solution (head chamber only; 60 s; 0.08
mL/min output). The aerosol was generated by a
Devilbiss 646 nebulizer (Devilbiss Co., Somerset, PA,
USA) operated by compressed air at 7.57 L/min
(Minipon 54B-588; Origin Medical Industry Co. Ltd,
Tokyo, Japan).
Measurement of cough response
Each conscious guinea pig was placed in a transparent
plastic box consisting of a head chamber (volume 1600
mL) isolated from a body chamber and pressure in 
the body chamber was recorded. Coughs were detected
as a transient change in the pressure (a rapid inspira-
tion followed by rapid expiration). To disregard motion-
and sneezing-related changes in pressure, movements
of guinea pigs were visually monitored. Coughs were
counted by a trained observer and were recognized by
characteristic animal posture and pressure transducer
recordings. Coughs were readily distinguished from
sneezes.
Capsaicin (30.5 mg) was dissolved in Tween 80 (1 mL)
and ethanol (1 mL) and then dissolved in physiologic
saline (8 mL) to make a stock solution of 10–2 mol/L,
which was stored at –20°C. This solution was diluted with
physiological saline to make solutions of 10–8, 10–6 and
10–4 mol/L. Each conscious guinea pig was exposed to
progressively increasing concentrations of the capsaicin
solution as an aerosol. Solutions were inhaled for 2 min
every 8 min from a Devilbiss 646 nebulizer (Devilbiss
Co.) operated by compressed air at 1.6 L/min (Iwaki Air
Pump AP-115AN; Iwaki Co. Ltd, Tokyo, Japan). The neb-
ulizer output was 0.037 mL/min. The number of coughs
was counted during a 2 min inhalation of each capsaicin
solution and during a subsequent 1 min observation
period.
Increased cough response after antigen 
challenge
Progressively increasing concentrations of capsaicin solu-
tion were inhaled by actively sensitized guinea pigs 
(n = 9) 24 h after a single challenge with an aerosolized
OA solution or by naïve guinea pigs (n = 9). The number
of coughs caused by each capsaicin solution was
counted and recorded.
Bronchoalveolar lavage (BAL) was performed after
completion of the capsaicin provocation to confirm
antigen-induced airway eosinophilic inflammation. Each
guinea pig was anesthetized with an intraperitoneal 
injection of 75 mg/kg sodium pentobarbital and the
trachea was cannulated with a polyethylene tube (2.5 mm
o.d.; 2.1 mm i.d.). The guinea pig was then artificially
ventilated by a small animal respiratory pump (model
1680; Harvard Apparatus Co. Inc., South Natick, MA,
USA) adjusted to a tidal volume of 10 mL/kg at a rate of
60 strokes/min. The lower airways were lavaged via the
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tracheal cannula using two 10 mL aliquots of physiologic
saline solution at 37°C. The fluid was recovered by gentle
aspiration with a disposable syringe. The BAL fluid (BALF)
was immediately centrifuged at 70 g for 8 min. After
discarding the supernatant, cells were washed twice in
Hank’s solution and resuspended in 1 mL Hank’s solu-
tion. They were then counted manually in a Burker
Chamber (Eruma Hanbai Kabushiki Gaisha, Tokyo,
Japan). Cytocentrifuged preparations (Cytospin 2; Shandon
Southern Products Ltd, Cheshire, UK) were stained 
with May–Giemsa and a differential cell count was per-
formed on 500 cells according to the standard mor-
phologic criteria.
Effect of histamine H1 receptor antagonists on
cough response to capsaicin
Two different histamine H1 receptor antagonists, azelas-
tine chloride and terfenadine, were used.
Azelastine, at doses of 0.1 (n = 6) or 1.0 mg/kg 
(n = 6), its vehicle (saline; n = 6), terfenadine, at doses of
0.2 (n = 6) or 2.0 mg/kg (n = 6), or its vehicle (saline; 
n = 6) was administered intraperitoneally 60 min before
the measurement of cough response to capsaicin in sensi-
tized guinea pigs. In addition, the effect of azelastine was
examined in naïve animals in the same manner (n = 6 for
each group).
Chemicals
The following chemicals were used: OA (Sigma Chemical
Co., St Louis, MO, USA), Al(OH)3 (Wako Pure Chemical
Industries, Osaka, Japan), sodium pentobarbital (Abbott
Laboratories, North Chicago, IL, USA), capsaicin (Sigma
Chemical Co.), dimethyl sulfoxide (DMSO; Wako Pure
Chemical Industries), ethanol (Sigma Chemical Co.),
azelastine (4-(P-chlorobenzyl)-2-[N-methyl-perhydro-
aze-pinyl-4]-1-(2H)-phthalazinone hydrochloride; Eisai
Co. Ltd, Tokyo, Japan), terfenadine ((±)- a -(P-tert-
butylphenyl)-4-(hydroxydiphenyl-methyl)-1-piperidine-
butnol; Nippon Heochst Marion Roussel Co. Ltd, Tokyo,
Japan) and physiological saline (Otsuka Pharmaceutical
Co. Ltd, Osaka, Japan).
Statistical analysis
Data are shown as the mean ± SEM. Statistical differences
were determined by parametric analysis of variance
(ANOVA) between groups. The relationship between the
percentage and number of BAL cells and the number of
coughs caused by inhaled capsaicin was analyzed using
simple regression analysis. Furthermore, multiple regres-
sion analysis was performed to assess contributions of
BAL cell components to the cough response. Significance
was based on a 95% confidence level (P < 0.05).
RESULTS
The number of coughs induced by 10–6 and 10–4 mol/L
capsaicin 24 h after antigen challenge in sensitized
guinea pigs was significantly greater than that in naïve
animals (Fig. 1), suggesting an increase in the cough
response after allergic reaction. Total cells and eosin-
ophils in BALF were significantly increased 24 h after
antigen challenge in sensitized animals compared with
naïve animals (Fig. 2), showing antigen-induced airway
eosinophil accumulation.
Percentages of eosinophils and macrophages in BALF
were significantly correlated with the number of coughs
induced by 10–6 and 10–4 mol/L capsaicin (Table 1), while
there was a significant correlation between the absolute
number of macrophages, lymphocytes, neutrophils and
eosinophils and 10–4 mol/L capsaicin-induced coughs
(Table 1). Accordingly, a multiple regression analysis was
performed with cough number caused by 10–4 mol/L
capsaicin as the dependent variable and the percentage
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Fig. 1 Cough response to inhaled capsaicin 24 h after an
antigen challenge in actively sensitized guinea pigs (h) and
non-sensitized (naïve) animals (j). Each column represents the
mean ± SEM (n = 9). **P < 0.01, ****P < 0.0001 compared
with naïve guinea pigs.
or number of BAL cells as independent variables. This
showed a significant contribution of eosinophil and
neutrophil numbers, but not macrophage or lympho-
cyte numbers, to the cough response. The overall
adjusted coefficient of multiple regression for predic-
tion of capsaicin cough response by the cell numbers
was 0.819 (P £ 0.0001) and the partial regression
coefficient for eosinophils and neutrophils was 0.556
(P £ 0.0001) and 0.398 (P £ 0.0001), respectively.
The same analysis for the percentage of BAL cells
showed that the overall coefficient was 0.892 
(P £ 0.0001) and only eosinophil percentage signifi-
cantly contributed to the cough response (partial
regression coefficient 0.831; P £ 0.0001).
Both azelastine and terfenadine dose-dependently
reduced the number of coughs elicited by each concen-
tration of capsaicin 24 h after antigen challenge in
sensitized guinea pigs (Figs 3,4), but azelastine had no
effect in naïve guinea pigs (Fig. 5).
DISCUSSION
In the present study, capsaicin was used to elicit coughing.
Capsaicin is the active ingredient of red pepper and has
been presumed to produce cough mainly by stimulating
C-fiber endings.10–12 However, because capsaicin also
stimulates some rapidly adapting receptors with myeli-
nated fibres, this view has been questioned.13,14 In the
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Fig. 2 Bronchoalveolar lavage cell
findings 24 h after an antigen challenge
in actively sensitized guinea pigs (h) and
nonsensitized (naïve) animals (j).Each
column represents the mean ± SEM 
(n = 9). **P < 0.01, ***P < 0.001 com-
pared with naïve guinea pigs.
Table 1 Relationship between number of coughs induced by inhaled capsaicin and cell differentials in bronchoalveolar lavage fluid
No. coughs
Concentration of inhaled capsaicin (mol/L)
10–8 10–6 10–4
r P r P r P
Total cells (cells/mL) 0.325 0.1881 0.487 0.0406 0.834 < 0.0001
Macrophages (%) –0.256 0.3048 –0.610 0.0072 –0.882 < 0.0001
(cells/mL) 0.336 0.1731 0.451 0.0603 0.793 < 0.0001
Lymphocytes (%) 0.269 0.2801 0.289 0.2445 0.224 0.3726
(cells/mL) 0.076 0.7644 0.384 0.1158 0.636 0.0045
Neutrophils (%) 0.408 0.0930 0.241 0.3350 0.050 0.8453
(cells/mL) 0.075 0.7659 0.511 0.0302 0.782 < 0.0001
Eosinophils (%) 0.392 0.1080 0.557 0.0163 0.899 < 0.0001
(cells/mL) 0.392 0.1079 0.487 0.0406 0.831 < 0.0001
Simple regression analysis was performed in two groups: sensitized and antigen-challenged guinea pigs (n = 9) and naïve animals (n = 9).
r = regression coefficient.
present study, capsaicin was used as a commonly used
inducer of cough to examine overall cough sensitivity.
In the present study, the number of coughs induced by
inhaled capsaicin was significantly increased 24 h after a
single aerosolized antigen challenge in actively sensitized
guinea pigs. The histamine H1 receptor antagonists aze-
lastine and terfenadine reduced the antigen-induced
increase in cough response to inhaled capsaicin in sensi-
tized guinea pigs, but azelastine had no effect on the
cough response in naïve guinea pigs. Because it has
been confirmed that the bronchodilators procaterol and
atropine have no effect on antigen-induced increases 
in cough response (Q Liu, unpubl. data, 1998), the
increase in cough response in the present study is thought
to result from antigen-induced increases in cough recep-
tor sensitivity in spite of bronchospasm.
Antihistamines have been shown to have an antitussive
effect on atopic cough,1–3 cough due to upper respiratory
tract stimulation by post-nasal drip associated with the
common cold15 and allergic cough.16 Although cough
sensitivity is heightened in atopic cough,1–3 but not in
cough due to post-nasal drip,17 it has not been reported
whether cough sensitivity is increased or not in allergic
cough. Bolser et al.7 have shown that both loratadine 
and chlorpheniramine inhibit antigen-induced cough in
actively sensitized guinea pigs and capsaicin-induced
cough in naïve guinea pigs. They have also shown that
salbutamol reduces both the allergic cough in sensitized
animals and the capsaicin-induced cough in naïve
animals, suggesting the antigen-induced cough may
result from antigen-induced bronchoconstriction. The
antitussive effects of loratadine and chlorpheniramine 
on capsaicin-induced cough are different from the result
of the present study, namely that azelastine did not affect
cough induced by capsaicin in naïve guinea pigs.
Chlorpheniramine is a first-generation antihistamine
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Fig. 4 Effect of terfenadine on cough response to capsaicin
24 h after antigen challenge in actively sensitized guinea pigs.
(h), 0.2 mg/kg terfenadine; ( ), 2.0 mg/kg terfenadine(j),
vehicle (saline). Each column represents the mean ± SEM 
(n = 6). ****P < 0.0001 compared with vehicle.
Fig. 5 Effect of azelastine on cough response to capsaicin in
non-sensitized (naïve) guinea pigs. (h), 0.1 mg/kg azelastine;
( ), 1.0 mg/kg azelastine; (j), vehicle (saline). Each column
represents the mean ± SEM (n = 6).
Fig. 3 Effect of azelastine on cough response to capsaicin
24 h after antigen challenge in actively sensitized guinea pigs.
(h), 0.1 mg/kg azelastine; ( ), 1.0 mg/kg azelastine; (j),
vehicle (saline). Each column represents the mean ± SEM 
(n = 6). **P < 0.01, ***P < 0.001, ****P < 0.0001 com-
pared with vehicle.
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having sedative and anticholinergic activity, but lorata-
dine, azelastine and terfenadine are second-generation
antihistamines (histamine H1 receptor antagonists) with
little or no sedative or anticholinergic effects. Because
anticholinergics have been shown to have antitussive
effects on capsaicin-induced cough in naïve guinea pigs,7
it is likely that the antitussive effect of chlorpheniramine
may be due to its anticholinergic activity. Although the
exact reason for the discrepancy of the effects on cap-
saicin-induced cough in naïve guinea pigs between
azelastine in the present study and loratadine in the study
of Bolser et al. is not known, the results of the present study
are in agreement with results of human studies. Choudry
et al.18 have shown that prior inhalation of histamine does
not effect capsaicin-induced cough in normal humans
and Studham and Fuller19 have reported that oral terfena-
dine has no effect on cough elicited by capsaicin in
normal volunteers. The latter results have been confirmed
using azelastine (Q Liu, unpubl. data, 1998). It is possible
that the dose of loratadine (10 mg/kg) used that inhibited
capsaicin-induced cough in naïve guinea pigs was rela-
tively high so that the antitussive effects of loratadine may
have been due to unknown pharmacologic properties of
the drug, other than histamine H1 receptor antagonism.
Accordingly, it is proposed that histamine H1 receptor
antagonists have no direct effect on capsaicin-induced
cough in naïve guinea pigs as well as in normal humans.
Thus, the inhibitory effect of azelastine and terfenadine on
the increased cough sensitivity induced by antigen chal-
lenge is likely to be due to indirect effects of the drugs on
cough receptor sensitivity. Because atropine did not alter
the increased cough sensitivity induced by an airway aller-
gic reaction in the same experimental system (Q Liu,
unpubl. data, 1998), it is unlikely that the inhibitory effects
of azelastine and terfenadine are due to their anticholiner-
gic activity. Intrinsic histamine released by antigen
challenge may potentiate airway cough sensitivity.
In the present study, the effect of azelastine or terfe-
nadine on BAL cell components was not examined.
Chand et al.20 have clearly shown that aeroantigen-
induced bronchial eosinophilia is not inhibited by
terfenadine when it is administered 4 h after antigen
challenge, whereas histamine H1 receptor antagonists
have been reported to suppress allergic eosinophilic
infiltration in the BAL of guinea pigs when administered
prophylactically. Accordingly, it is suggested that hista-
mine H1 receptor antagonists inhibit antigen-induced
increases in cough receptor sensitivity via antagonism
of the actions of histamine, which is released by airway
allergic reactions, without direct effect on airway inflam-
matory cell components.
In conclusion, because there has been no direct evi-
dence for the involvement of histamine in increased
cough sensitivity in humans or animal experiments, espe-
cially that induced by airway allergic reactions or
eosinophilic inflammation, the effects of the histamine 
H1 receptor antagonists azelastine and terfenadine on
increased cough sensitivity induced by allergic reactions
in actively sensitized guinea pigs were examined. Both
histamine H1 receptor antagonists dose-dependently
reduced antigen-induced increases in cough sensitivity to
capsaicin in sensitized guinea pigs, whereas azelastine
had no effect on the cough response in naïve animals.
These findings strongly suggest the involvement of intrin-
sic histamine in the heightened cough sensitivity induced
by allergic reactions. Namely, histamine released by
allergic reactions may sensitize airway cough receptors,
but aerosolized capsaicin-induced cough may not be
mediated by histamine release.
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